Dangerous Drugs (Supply to Addicts) Regulations 1968

BioCare In-House Expertise to Guide Customers on Effectively Preparing for the Drug Supply Chain Security Act (DSCSA)

Retrieved on:

Thursday, November 9, 2023

FDA, Food, Dangerous Drugs (Supply to Addicts) Regulations 1968, History, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Regulation, Health, DSCSA, Safety, Nobel Biocare, Patient, Communication, Medical device, Quality

The DSCSA final phase includes the enforcement of exchanging serialized data at the package level and kicks in on November 27, 2024.

Key Points:

The DSCSA final phase includes the enforcement of exchanging serialized data at the package level and kicks in on November 27, 2024.
As the intermediary between pharmaceutical manufacturers and healthcare providers, BioCare plays a vital role to ensuring the integrity and safety of the pharmaceutical supply chain.
By acting as a knowledgeable and supportive bridge between the manufacturers and customer healthcare entities, BioCare effectively enhances compliance and contributes to the overall safety and trustworthiness of the pharmaceutical supply chain.
A copy of the BioCare white paper, "The Drug Supply Chain Security Act (DSCSA) & How Companies Can Prepare for Compliance, is available here .

LSPedia and BestRx Have Partnered to Give Pharmacies Access to an Integrated, Comprehensive DSCSA Compliance Solution

Retrieved on:

Monday, October 23, 2023

The partnership also provides BestRx pharmacies with access to special pricing for LSPedia's robust compliance solution, eliminating price barriers.

Key Points:

The partnership also provides BestRx pharmacies with access to special pricing for LSPedia's robust compliance solution, eliminating price barriers.
"Given the complexity of the DSCSA requirements, we recognized how important it is for independent pharmacies to have access to affordable, complete compliance solutions," said Hemal Desai, President of BestRx.
OneScan Pharmacy Pro is the industry's gold-standard DSCSA compliance solution, thanks to its user-friendly interface, affordability, and forward-looking features that cover both current and future provisions of DSCSA.
Beyond compliance, the solution provides additional value for pharmacies with inventory management features that save time and eliminate repetitive manual entry tasks.

Inmar Intelligence Welcomes Brian Nightengale as EVP & President, Healthcare Solutions, Bolstering Its Commitment to Healthcare Innovation

Retrieved on:

Tuesday, October 10, 2023

Dangerous Drugs (Supply to Addicts) Regulations 1968, USP, Long-term care, Growth, Intelligence, Safety, Pharmacy, DSCSA, Management, Pharmaceutical industry

Winston-Salem, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Inmar Intelligence , the leading provider of data-driven healthcare technology solutions, today announced the appointment of Brian Nightengale as Executive Vice President & President, Healthcare Solutions.

Key Points:

Winston-Salem, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Inmar Intelligence , the leading provider of data-driven healthcare technology solutions, today announced the appointment of Brian Nightengale as Executive Vice President & President, Healthcare Solutions.
Brian brings a wealth of expertise spanning the pharmaceutical supply chain, clinical care, and strategic commercialization, that will serve as a critical addition to Inmar Intelligence's healthcare leadership team.
Brian’s extensive background will play a pivotal role in advancing Inmar Intelligence's mission to drive safety, create operational efficiencies, and demonstrate value to stakeholders throughout the healthcare supply chain.
For more information about Inmar Intelligence's healthcare solutions and its continued commitment to healthcare innovation, please visit www.inmar.com/healthcare .

LSPedia Selects Droguería Betances as an Official Reseller of OneScan Pharmacy Pro, the Leading FDA DSCSA Solution for Pharmacies

Retrieved on:

Monday, September 18, 2023

EPCIS, Partnership, Pharmacy, Sales & Marketing Executives International, Lung compliance, Dangerous Drugs (Supply to Addicts) Regulations 1968, Patient, DSCSA, FDA, Grocery store

LSPedia's OneScan Pharmacy Pro enables any pharmacy to quickly achieve comprehensive DSCSA compliance, offering seamless integration with pharmacy systems as well as modules that cover essential functions such as serialization, EPCIS data, and verification.

Key Points:

LSPedia's OneScan Pharmacy Pro enables any pharmacy to quickly achieve comprehensive DSCSA compliance, offering seamless integration with pharmacy systems as well as modules that cover essential functions such as serialization, EPCIS data, and verification.
Juan Carlos Hernandez, President of Droguería Betances, said the partnership provides vital support for Puerto Rico's pharmacies.
"Droguería Betances is exemplary in its dedication to compliance and use of best-in-class technology," said LSPedia's Daniel MacKinnon, Vice President of Sales & Marketing.
With access to this solution, pharmacies can meet both their current and their future obligations under DSCSA, and that's going to protect patients, support business growth, and strengthen the entire supply chain."

LSPedia Expands Leadership Capability, Adding Rose Campasano as Vice President of Services

Retrieved on:

Thursday, September 7, 2023

EPCIS, Professional services, Software as a service, Astellas Pharma, Strategic planning, Organization, Dangerous Drugs (Supply to Addicts) Regulations 1968, Food and Drug Administration, Patient, DSCSA, FDA, Food, Pharmaceutical industry, EU

FARMINGTON HILLS, Mich., Sept. 7, 2023 /PRNewswire/ -- LSPedia, a software-as-a-service (SaaS) provider specializing in product traceability solutions for the pharmaceutical industry, announced that it has named Rose Campasano to its leadership team as Vice President of Services.

Key Points:

FARMINGTON HILLS, Mich., Sept. 7, 2023 /PRNewswire/ -- LSPedia, a software-as-a-service (SaaS) provider specializing in product traceability solutions for the pharmaceutical industry, announced that it has named Rose Campasano to its leadership team as Vice President of Services.
With experience as Vice President of Professional Services at RFXCEL and leadership roles at Astellas, her hands-on expertise in navigating compliance complexities and strategic planning are standout qualities.
In her new capacity, Campasano collaborates closely with LSPedia CEO Riya Cao.
"At LSPedia, we are thrilled to have Rose on board leading our service offerings during this pivotal time in the pharmaceutical industry.

NABP Launches Pulse Interoperable Partner Program to Accelerate Interoperability in Drug Supply Chain

Retrieved on:

Tuesday, August 29, 2023

NABP, DSCSA, Dangerous Drugs (Supply to Addicts) Regulations 1968, National Association, Doctor of Pharmacy, Patient, Pharmacist, Medical device, Asset management, Pulse

MOUNT PROSPECT, IL, Aug. 29, 2023 (GLOBE NEWSWIRE) -- The National Association of Boards of Pharmacy® (NABP®) today announced the launch of the Pulse Interoperable Partner program, a new initiative that will provide a framework for solution providers to integrate directly with Pulse by NABP™ and help accelerate interoperability in the drug supply chain.

Key Points:

MOUNT PROSPECT, IL, Aug. 29, 2023 (GLOBE NEWSWIRE) -- The National Association of Boards of Pharmacy® (NABP®) today announced the launch of the Pulse Interoperable Partner program, a new initiative that will provide a framework for solution providers to integrate directly with Pulse by NABP™ and help accelerate interoperability in the drug supply chain.
“The Pulse Interoperable Partner program is a critical step in our efforts to create a more interoperable drug supply chain,” said NABP Executive Director/Secretary Lemrey “Al” Carter, PharmD, MS, RPh.
Most importantly, we are all working together to create a more secure supply chain to protect patients.”
The Pulse Interoperable Partner program is open to all solution providers that serve authorized trading partners and wish to connect to Pulse.
Participating solution providers will receive technical documentation from NABP and will be listed on the Pulse website as a Pulse Interoperable Partner in the future.

Tecsys Recognized in 2023 Gartner® Critical Capabilities for Warehouse Management Systems

Retrieved on:

Tuesday, August 22, 2023

WMS, Analytics, Use, Nursing, Health care, Transportation management system, Research, Pharmacy, TCS, Dangerous Drugs (Supply to Addicts) Regulations 1968, Warehouse management system, Publication, Distribution, DSCSA, Architecture, TSX, Warehouse, Gartner

(TSX: TCS), an industry leader in supply chain management software, today announces its Elite™ WMS platform has been recognized in the 2023 Gartner® Critical Capabilities for Warehouse Management Systems (WMS) report.

Key Points:

(TSX: TCS), an industry leader in supply chain management software, today announces its Elite™ WMS platform has been recognized in the 2023 Gartner® Critical Capabilities for Warehouse Management Systems (WMS) report.
"We are proud of our recognition in the Gartner® Critical Capabilities for Warehouse Management Systems report, and feel it reflects our continuous efforts to provide our WMS customers with the advanced functionality they need to get the most out of their supply chain," says Peter Brereton, president and CEO of Tecsys.
Further, Tecsys' strategic industry partnerships make it easier than ever for health systems to tackle their end-to-end supply chain challenges.
Gartner, Critical Capabilities for Warehouse Management Systems, 27 July 2023, Simon Tunstall, et.

TraceLink Collaborates with GS1 US to Author GS1 US Addendum Guidance and XML Examples for GS1 US DSCSA Implementation Guideline R1.3 to Support EPCIS Data Exchange

Retrieved on:

Thursday, August 17, 2023

EPCIS, Communication, GS1, Partnership, XML, Organization, Dangerous Drugs (Supply to Addicts) Regulations 1968, Drug Quality and Security Act, Documentation, Patient safety, DSCSA, FDA, GS1 US, Cryptocurrency, Medical device

BOSTON, Aug. 17, 2023 /PRNewswire/ -- TraceLink Inc., the leading digital network platform company enabling end-to-end product orchestration by connecting more than 290,000 healthcare and life sciences entities through its B2N Integrate-Once™ network, is proud to announce its continuing support of Drug Supply Chain Security Act (DSCSA) 2023 readiness through its partnership with GS1 in the authoring of the GS1 US Addendum Guidance and XML Examples for GS1 US DSCSA Implementation Guideline R1.3. An early adopter of GS1 standards, TraceLink has now exchanged over one million DSCSA-compliance EPCIS transactions between trading partners on the TraceLink network, with over 1,075 companies now being EPCIS-enabled for DSCSA compliance data exchange in preparation for November 2023 deadlines.

Key Points:

An early adopter of GS1 standards, TraceLink has now exchanged over one million DSCSA-compliance EPCIS transactions between trading partners on the TraceLink network, with over 1,075 companies now being EPCIS-enabled for DSCSA compliance data exchange in preparation for November 2023 deadlines.
The latest implementation documents, published by GS1 US on May 26th, 2023, serve as an EPCIS serialized data exchange implementation blueprint for companies across the US pharmaceutical and healthcare supply chain.
The expanded documentation provides detailed descriptions of end-to-end trading partner event choreographies for serialized item traceability use cases under DSCSA.
GS1 is a global, non-profit organization dedicated to the design and implementation of global standards for efficient business communication.

TraceLink Collaborates with GS1 US to Author GS1 US Addendum Guidance and XML Examples for GS1 US DSCSA Implementation Guideline R1.3 to Support EPCIS Data Exchange

Retrieved on:

Thursday, August 17, 2023

BOSTON, Aug. 16, 2023 /PRNewswire/ -- TraceLink Inc., the leading digital network platform company enabling end-to-end product orchestration by connecting more than 290,000 healthcare and life sciences entities through its B2N Integrate-Once™ network, is proud to announce its continuing support of Drug Supply Chain Security Act (DSCSA) 2023 readiness through its partnership with GS1 in the authoring of the GS1 US Addendum Guidance and XML Examples for GS1 US DSCSA Implementation Guideline R1.3. An early adopter of GS1 standards, TraceLink has now exchanged over one million DSCSA-compliance EPCIS transactions between trading partners on the TraceLink network, with over 1,075 companies now being EPCIS-enabled for DSCSA compliance data exchange in preparation for November 2023 deadlines.

Key Points:

An early adopter of GS1 standards, TraceLink has now exchanged over one million DSCSA-compliance EPCIS transactions between trading partners on the TraceLink network, with over 1,075 companies now being EPCIS-enabled for DSCSA compliance data exchange in preparation for November 2023 deadlines.
"Given the sense of urgency for November 2023, we want to jumpstart EPCIS implementations..." said Elizabeth Waldorf.
The latest implementation documents, published by GS1 US on May 26th, 2023, serve as an EPCIS serialized data exchange implementation blueprint for companies across the US pharmaceutical and healthcare supply chain.
The expanded documentation provides detailed descriptions of end-to-end trading partner event choreographies for serialized item traceability use cases under DSCSA.

LSPedia's Industry-Wide Advances in DSCSA Compliance Recognized by Inc. 5000 Ranking

Retrieved on:

Tuesday, August 15, 2023

EPCIS, Software as a service, CMOS, Dangerous Drugs (Supply to Addicts) Regulations 1968, Patient, DSCSA, Growth, FDA, Pharmaceutical industry, Medical device

With full regulatory enforcement of DSCSA set to take effect on November 27, 2023, LSPedia's OneScan solution has become the industry's leading solution for comprehensive, affordable compliance.

Key Points:

With full regulatory enforcement of DSCSA set to take effect on November 27, 2023, LSPedia's OneScan solution has become the industry's leading solution for comprehensive, affordable compliance.
OneScan enables vital DSCSA functions such as EPCIS data exchange, trading partner onboarding, and product reconciliation with data.
Even as DSCSA transforms the pharmaceutical supply chain, OneScan brings stability and efficiency to customers' operations.
Additionally, LSPedia's subsidiary Proactive Resource Group fully manages DSCSA compliance through outsourcing, reaffirming LSPedia's commitment to holistic solutions that enhance efficiency and compliance.